HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy.

AbstractBACKGROUND:
Co-delivery of gene and anticancer drug into the same cancer cells or tissues by multifunctional nanocarriers may provide a new paradigm in cancer treatment. In this study, nanostructured lipid carriers (NLCs) were constructed as multifunctional nanomedicine for co-delivery of enhanced green fluorescence protein plasmid (DNA) and temozolomide (TMZ).
METHODS:
TMZ- and DNA-loaded NLCs (TMZ/DNA-NLCs) were prepared. Their particle size, zeta potential, gene-loading capacity (GL) and drug encapsulation efficiency (EE) were evaluated. In vitro cytotoxicity study TMZ/DNA-NLCs was tested in U87 malignant glioma cells (U87 MG cells). In vivo gene transfection and anti-tumor efficacy of the carriers were evaluated on mice bearing malignant glioma model.
RESULTS:
The optimum TMZ/DNA-NLCs formulations with the particle size of 179 nm and with a +23 mV surface charge; got 91% of GL and 83% of EE. The growth of U87 MG cells in vitro was obviously inhibited. TMZ/DNA-NLCs also displayed the highest gene transfection efficiency and the best antitumor activity than other formulations in vivo.
CONCLUSION:
The results demonstrated that TMZ/DNA-NLCs were efficient in selective delivery to malignant glioma cells. Also TMZ/DNA-NLCs transfer both drug and gene to the gliomatosis cerebri, enhance the antitumor capacity and gene transfection efficacy. Thus, TMZ/DNA-NLCs could prove to be a superior co-delivery nanomedicine to achieve therapeutic efficacy and this report could be a new promising strategy for treatment in malignant gliomatosis cerebri.
AuthorsZhihua Chen, Xianliang Lai, Shuxin Song, Xingen Zhu, Jianming Zhu
JournalDrug delivery (Drug Deliv) Vol. 23 Issue 4 Pg. 1369-73 (May 2016) ISSN: 1521-0464 [Electronic] England
PMID26017099 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Drug Carriers
  • Lipids
  • Dacarbazine
  • DNA
  • Temozolomide
Topics
  • Animals
  • Antineoplastic Agents (chemistry, metabolism, pharmacology)
  • Cell Line, Tumor
  • Chemistry, Pharmaceutical
  • DNA (chemistry, genetics, pharmacology)
  • Dacarbazine (analogs & derivatives, chemistry, metabolism, pharmacology)
  • Drug Carriers
  • Drug Delivery Systems
  • Humans
  • Lipids (chemistry)
  • Mice
  • Nanomedicine
  • Nanostructures
  • Neoplasms, Neuroepithelial (chemistry, drug therapy)
  • Temozolomide
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: